Categories Earnings, Finance

What to expect from American Express’ (AXP) Q3 earnings report?

American Express Company (NYSE: AXP) is slated to report third quarter 2019 earnings results on Friday, October 18, before the market opens. Analysts expect the company to report earnings of $2.03 per share. This compares to EPS of $1.88 reported a year ago. Sales are expected to increase nearly 8% from last year to $10.95 billion.

The financial services industry is tackling interest rate cuts and adverse economic conditions which leads to uncertainty in terms of earnings. However, strength in consumer banking and growth in the small and medium-sized enterprise sector are likely to benefit the company.

American Express has seen strength in cardmember spending and loan volumes and this trend can be expected to continue in the third quarter. The company is also likely to benefit from its business investments, such as the acquisition of digital payment automation platform, acompay, from ACOM Solutions.

In the second quarter of 2019, American Express topped revenue and earnings estimates. Revenue rose 8% to $10.8 billion while adjusted EPS increased 13% to $2.07.

Also read: Goldman Sachs Q3 2019 Earnings Report

For the full year of 2019, American Express expects reported EPS to come in the range of $7.64-8.14 and adjusted EPS to be $7.85-8.35.

Shares have gained 24% so far this year. The majority of analysts have rated the stock as Hold and it has an average price target of $127.44.

Goldman Sachs (NYSE: GS) and Citigroup (NYSE: C) reported their third quarter 2019 earnings results today. Goldman beat revenue estimates but missed earnings expectations. Citigroup beat earnings estimates.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top